Research Analysts Set Expectations for MDGL Q1 Earnings
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Analysts at B. Riley raised their Q1 2025 earnings per share estimates for Madrigal Pharmaceuticals in a research report issued on Thursday, February 27th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will earn ($2.71) per share for the quarter, up from their prior […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Analysts at B. Riley raised their Q1 2025 earnings per share estimates for Madrigal Pharmaceuticals in a research report issued on Thursday, February 27th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will earn ($2.71) per share for the quarter, up from their prior […]
